Latest News and Press Releases

Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York – 4BIO Capital (“4BIO” or “the Group”), an international...

Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia – 4BIO Capital...

Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors 4BIO Capital appointed as highly specialized asset manager for Harbor’s disruptive innovation strategy after competitive...

Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...

Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...

Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...

Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...

Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...